PASCALL + WATSON LIMITED

Company number 01711056 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

1. Financial Health Score: A-

Explanation: Pascall + Watson Limited exhibits the robust vitality of a well-conditioned athlete. The firm has demonstrated an exceptional capacity to grow its revenue base and maintain profitability in a challenging macroeconomic environment. With strong cash reserves, a solid balance sheet, and a diversified project portfolio, the company shows no immediate symptoms of financial distress. The slight deduction from a perfect score is merely a precautionary measure, acknowledging the inherent risks of rapid international expansion and reliance on large-scale infrastructure frameworks.

2. Key Vital Signs

  • Pulse Rate (Revenue Growth): The company's top-line revenue is racing at a healthy clip. From £10.6m in 2021, revenue surged to £24.0m in 2022, and the latest strategic report indicates a further climb to £33.0m in 2024 and £35.1m in 2025. This steady, rapid heartbeat indicates strong market demand and successful project acquisition.
  • Metabolism (Profitability): The business is converting its intake into energy effectively. A pre-tax profit of £2.8m in 2025 (up from £2.0m in 2024) yields a healthy operating margin of roughly 8%. This indicates that the firm is not just growing its top line but is managing its costs and project delivery efficiently.
  • Blood Flow (Liquidity & Cash Reserves): In 2022, the company held £5.89m in cash against total liabilities of £7.61m. This represents excellent "hydration" and working capital flexibility, allowing the firm to fund operations, invest in new technologies like AI, and weather any short-term payment delays from clients without risking cardiac arrest.
  • Bone Density (Net Assets & Equity): Net assets stood at £11.9m at the end of 2022, backed by strong retained earnings. This provides a sturdy skeletal structure, offering resilience against external shocks and a strong foundation for future borrowing or investment if needed.

3. Diagnosis

The patient is in a state of robust financial health with no chronic conditions detected. The diagnostic data reveals a business that has successfully rehabilitated and expanded post-pandemic. The diversification across multiple sectors—Aviation, Rail and Ports, Education, and Leisure—acts as a robust immune system, protecting the firm from sector-specific downturns.

The geographical spread (UK, Ireland, UAE, and Africa) provides excellent resilience, though it introduces minor exposure to foreign exchange fluctuations and geopolitical variables. The strategic report highlights a proactive approach to "future-proofing" the business through investments in AI, BIM outsourcing, and sustainability credentials (ISO14068, Net Zero targets). This forward-looking posture suggests management is focused on preventative care rather than just treating symptoms as they arise.

4. Recommendations

To maintain this excellent physical condition and optimize long-term wellness, the following preventative measures are recommended:

  • Cardiovascular Conditioning (Cash Flow Management): As the firm undertakes larger, complex international projects, maintain strict oversight on working capital. Large infrastructure projects can often have lumpy payment milestones. Keep the "blood pressure" stable by rigorously chasing receivables and managing payables to ensure cash reserves remain robust.
  • Immune System Support (Risk Diversification): While the aviation sector is currently booming, it is historically cyclical. Continue to balance the portfolio with public sector, education, and healthcare projects to ensure that a downturn in one sector does not compromise the overall organism.
  • Nutritional Optimization (Margin Enhancement): The exploration of AI and BIM outsourcing is an excellent prescription for improving operational efficiency. Continue to scale these initiatives to protect and potentially improve the 8% profit margin, especially as competitive pressures on large framework bids can often squeeze pricing.
  • Vitamin Supplements (Strategic Investments): The ongoing investment in digital tools, sustainability, and human capital is highly beneficial. Ensure that the capital expenditure on these areas is measured and yields a tangible return on investment to avoid unnecessary financial weight gain.

Perspective: Financial Health Diagnostician · Model: glm-5.2 · Generated 7 October 2026